Using single nucleotide polymorphisms as a means to understanding the pathophysiology of asthma

Respiratory Research

Volumn 2, Issue 2, 2001, Pages 102-112

  Palmer, Lyle J ^a,b   Cookson, William O C M ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Association studies; Asthma; Genetics; Review; SNP

Indexed keywords

ASTHMA; BIOTECHNOLOGY; CHILDHOOD DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; COST OF ILLNESS; DEVELOPED COUNTRY; DISEASE PREDISPOSITION; GENE CONSTRUCT; GENE LOCUS; GENETIC DISORDER; GENOME; GENOTYPE; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ASTHMA; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0035719983     PISSN: 14659921     EISSN: None     Source Type: Journal    
DOI: 10.1186/rr45     Document Type: Review

References (163)

1. International Study of Asthma and Allergies in Childhood (ISAAC): Rationale and methods
2. The burden of pediatric asthma
3. A national estimate of the economic costs of asthma
4. The alliance of genes and environment in asthma and allergy
5. Localisation of atopy and β subunit of high-affinity IgE receptor (FCεRI) on chromosome 11q
6. Association of asthma with serum IgE levels and skin-test reactivity to allergens
7. Relation of the course of bronchial responsiveness from age 9 to age 15 to allergy
8. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobin E concentrations
9. Asthma in children less than 5 years of age: Eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms
10. Eosinophil inflammation in asthma
11. The genetics of asthma
12. Genomic approaches to understanding asthma
13. Worldwide trends in asthma morbidity and mortality. Explanation of trends
14. The problem of atopic eczema: Aetiological clues from the environment and lifestyles
15. Contributing factors to the pathobiology. The genetics of asthma
16. A genome-wide search for quantitative trait loci underlying asthma
17. CSGA: A genome-wide search for asthma susceptibility loci in ethnically diverse populations
18. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma
19. A genome-wide search for linkage to asthma
20. Cystic fibrosis - Genotypic and phenotypic variations
21. Genetic dissection of complex traits
22. Case-control association studies for the genetics of complex respiratory diseases
23. Polygenic disease: Methods for mapping complex disease traits
24. Genetic epidemiology of single-nucleotide polymorphisms
25. The future of genetic studies of complex human diseases
26. Atopy and asthma
27. Construction of a genetic linkage map in man using restriction fragment length polymorphisms
28. A general approach to single-nucleotide polymorphism discovery
29. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome
30. High-resolution genetic mapping of complex traits
31. Searching for genetic determinants in the new millennium
32. Single nucleotide polymorphisms and the future of genetic epidemiology
33. Single nucleotide polymorphisms as tools in human genetics
34. Genetic association studies in complex diseases
35. The genetic dissection of multifactorial traits
36. Serial analysis of gene expression
37. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
38. SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease
39. An analysis of strategies for discovery of single-nucleotide polymorphisms
40. The Human Genome Project - An overview
41. Human genome research. SNP mappers confront reality and find it daunting
42. New goals for the US Human Genome Project: 1998-2003
43. Japan bids to catch up on gene sequencing
44. Snipping away at genome patenting
45. A second private genome project
46. As consortium plans free SNP map of human genome
47. Characterization of single-nucleotide polymorphisms in coding regions of human genes
48. Reading bits of genetic information: Methods for single-nucleotide polymorphism analysis
49. DNA chip technology
50. DNA chips: An array of possibilities
51. An analytic solution to single nucleotide polymorphism error-detection rates in nuclear families: Implications for study design
52. Variations on a theme: Cataloging human DNA sequence variation
53. The use of a genetic map of biallelic markers in linkage studies
54. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
55. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
56. Identification of clusters of biallelic polymorphic sequence-tagged sites (pSTSs) that generate highly informative and automatable markers for genetic linkage mapping
57. It's raining SNPs, hallelujah?
58. Mapping genes that underlie ethnic differences in disease risk: Methods for detecting linkage in admixed populations, by conditioning on parental admixture
59. Usefulness of single nucleotide polymorphism data for estimating population parameters
60. n repetitive sequences in mammalian genomes
61. The essence of SNPs
62. Comparison of the power and accuracy of biallelic and microsatellite markers in population-based gene-mapping methods
63. Linkage disequilibrium mapping of complex disease: Fantasy or reality?
64. Mapping of complex traits by single-nucleotide polymorphisms
65. The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits
66. A coalescent approach to study linkage disequilibrium between single-nucleotide polymorphisms
67. Data mining applied to linkage disequilibrium mapping
68. Family-based linkage disequilibrium mapping using SNP marker haplotypes: Application to a potential locus for schizophrenia at chromosome 22q11
69. A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci
70. Mapping a disease locus by allelic association
71. Combined analysis of genetic segregation and linkage under an oligogenic model
72. Estimation of population parameters and recombination rates from single nucleotide polymorphisms
73. Dog allergy, a model for allergy genetics
74. Expression of airway hyperreactivity to acetylcholine as a simple autosomal recessive trait in mice
75. Genetics of immunoresponsiveness to natural antigens in the mouse
76. 2 injections in BN and LEW rats: A genetic analysis
77. Genetic control of eosinophilia in parasitic infections: Responses of mouse strains to treatment with cyclophosphamide and parastite antigen
78. Eosinophil responses in sheep selected for high and low responsiveness to Trichostrongylus colubriformis
79. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice
80. A genome-wide screen for asthma-associated quantitative trait loci in a mouse model of allergic asthma
81. CC chemokine receptor-2 is not essential for the development of antigen-induced pulmonary eosinophilia and airway hyperresponsiveness
82. Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse
83. Gene identification in asthma and allergy
84. The future is function
85. Prospects for whole-genome linkage disequilibrium mapping of common disease genes
86. Extent and distribution of linkage disequilibrium in three genomic regions
87. Linkage disequilibrium as a gene-mapping tool
88. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy
89. Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy
90. Induction and regulation of the IgE response
91. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5
92. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties
93. 2-adrenergic receptors in airway smooth muscle alters myocyte function and ablates bronchial hyperreactivity
94. 2-adrenergic receptor in normal and asthmatic subjects
95. 2-adrenergic receptor variants in asthma
96. 2-adrenoceptor (ADRB2) haplotypes. A population study
97. 2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma
98. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing
99. Genetics of atopy and asthma: Promoter-based candidate gene studies for IL-4
100. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E
101. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children
102. Genetic variants of IL-13 signalling and human asthma and atopy
103. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
104. Atopy and asthma: Genetic variants of IL-4 and IL-13 signalling
105. Childhood atopic asthma: Positive association with a polymorphism of IL-4 receptor α gene but not with that of IL-4 promoter or Fcε receptor Iβ gene
106. The R576 IL-4 receptor α allele correlates with asthma severity
107. A new variant of the β subunit of the high-affinity receptor for immunoglobin E (FC-ε-RI-β E237G) - Associations with measures of atopy and bronchial hyperresponsiveness
108. Association between atopic asthma and a coding variant of FCεRIβ in a Japanese population
109. Linkage of high-affinity IgE receptor gene with bronchial hyperreactivity, even in the absence of atopy
110. Association of atopic dermatitis to the β subunit of the high affinity immunoglobulin E receptor
111. εR1-β polymorphism and total serum IgE levels in endemically parasitized Australian aborigines
112. Association between atopy and variants of the β subunit of the high-affinity immunoglobin E receptor
113. Association of HLA-DR3 with human immune response to Lol p I and Lol p II allergens in allergic subjects
114. Molecular genetics of human immune responsiveness to pollen allergens
115. HLA-DR and HLD-DP genotypes and immunoglobin E responses to common major allergens
116. Evidence of a strong, positive association between atopy and the HLA class II alleles DR4 and DR7
117. LTa Ncol polymorphism at the TNF locus correlates with clinical symptoms of asthma
118. Tumour necrosis factor haplotypes and asthma
119. Evidence for linkage for atopy and asthma to markers on chromosome 12q
120. Linkage of asthma and total serum IgE concentration to markers on chromosome 12q: Evidence from Afro-Caribbean and Caucasian populations
121. Genetic linkage of T-cell receptor α/δ complex to specific IgE responses
122. Alpha-1-antitrypsin levels and the prevalence of Pi variant phenotypes in asthmatic children
123. Protease inhibitor variants in children and young adults with chronic asthma
124. 1-antitrypsin deficiency in obstructive lung disease
125. 1, wheezing, and asthma
126. Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis
127. Heterozygotes for the ΔF508 cystic fibrosis allele are not protective against bronchial asthma
128. Correlation between atopy and Gm allotypes
129. The genetics of allergy - RFLP analysis of HLA and immunoglobulin heavy chain constant genes in Italian patients
130. A polymorphism of the CC16 gene is associated with an increased risk of asthma
131. Association between asthma and an intragenic variant of CC16 on chromosome 11q13
132. Association of CCR5 δ32 with reduced risk of asthma
133. + T lymphocytes
134. High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma
135. Single-nucleotide polymorphisms, haplotypes, and their relevance to pharmacogenetics
136. Pharmacogenetics and drug metabolism
137. Pharmacogenetics and psychopharmacotherapy
138. The use of single-nucleotide polymorphism maps in pharmacogenomics
139. Pharmacogenomics: The genomics of drug response
140. 2-adrenergic receptors: Relevance to asthma
141. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC
142. Pharmacogenetics of asthma
143. 2-adrenergic receptor on the response to regular use of albuterol in asthma
144. Pharmacogenetics of β-1- and β-2-adrenergic receptors
145. Histamine N-methyltransferase pharmacogenetics: Association of a common functional polymorphism with asthma
146. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
147. On the relative sample size required for multiple comparisons
148. Tech.sight. Genetic testing - Present and future
149. The human genome project and the future of diagnostics, treatment, and prevention
150. Ethical issues in genetic testing of children
151. The Nurses' Health Study: 20-year contribution to the understanding of health among women
152. The Busselton study: Mapping population health
153. Viral infections and the development of asthma
154. Environmental factors and asthma and allergy in schoolchildren from Western Australia
155. Cigarette smoking and health: The official statement of the American Thoracic Society
156. Diet as a risk factor for asthma
157. Maternal programming in asthma and allergy
158. Primary prevention of asthma and other allergic disorders
159. Heterozygous expression of insulin-dependent diabetes mellitus (IDDM) determinants in the HLA system
160. A new method for the evaluation of matches in non-recombining genomes: Application to Y-chromosomal short tandem repeat (STR) haplotypes in european males
161. Major factors influencing linkage disequilibrium by analysis of different chromosome regions in distinct populations: Demography, chromosome recombination frequency and selection
162. Linkage disequilibrium patterns vary with chromosomal location: A case study from the von Willebrand factor region
163. Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region